scispace - formally typeset
R

Russell Schachar

Researcher at University of Toronto

Publications -  313
Citations -  32380

Russell Schachar is an academic researcher from University of Toronto. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Autism spectrum disorder. The author has an hindex of 88, co-authored 277 publications receiving 28373 citations. Previous affiliations of Russell Schachar include University of California, San Diego & Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

S. Hong Lee, +405 more
- 01 Sep 2013 - 
TL;DR: Empirical evidence of shared genetic etiology for psychiatric disorders can inform nosology and encourages the investigation of common pathophysiologies for related disorders.
Journal ArticleDOI

Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder

Ditte Demontis, +126 more
- 01 Jan 2019 - 
TL;DR: A genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls identifies variants surpassing genome- wide significance in 12 independent loci and implicates neurodevelopmental pathways and conserved regions of the genome as being involved in underlying ADHD biology.
Journal ArticleDOI

Analysis of shared heritability in common disorders of the brain

Verneri Anttila, +720 more
- 22 Jun 2018 - 
TL;DR: It is demonstrated that, in the general population, the personality trait neuroticism is significantly correlated with almost every psychiatric disorder and migraine, and it is shown that both psychiatric and neurological disorders have robust correlations with cognitive and personality measures.
Journal ArticleDOI

Impulsivity and Inhibitory Control

TL;DR: This article found that impulsive people respond more slowly to signals to inhibit (stop signals) than non-impulsive people when they hear a stop signal, and that the delay between the go signal and the stop signal was determined by a tracking procedure designed to allow subjects to inhibit on 50% of the trials.